Brief: Marksans Pharma Sept-Quarter Consol Profit Falls
10/11/2021 05:40
Nov 10 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARKSANS PHARMA SEPT-QUARTER CONSOL PROFIT 462.9 MILLION RUPEES VERSUS 507.3 MILLION
RUPEES YEAR
AGO
* MARKSANS PHARMA SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 3.61 BILLION RUPEES VERSUS
3.56
BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE784r18
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg